SG Americas Securities’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $785K | Sell |
155,231
-6,837
| -4% | -$34.6K | ﹤0.01% | 1202 |
|
|
2025
Q1 | $857K | Buy |
162,068
+112,725
| +228% | +$596K | ﹤0.01% | 1167 |
|
|
2024
Q4 | $334K | Sell |
49,343
-39,982
| -45% | -$271K | ﹤0.01% | 1483 |
|
|
2024
Q3 | $589K | Buy |
89,325
+63,727
| +249% | +$420K | ﹤0.01% | 1355 |
|
|
2024
Q2 | $192K | Buy |
+25,598
| New | +$192K | ﹤0.01% | 1932 |
|
|
2024
Q1 | – | Sell |
-22,186
| Closed | -$219K | – | 2945 |
|
|
2023
Q4 | $219K | Sell |
22,186
-16,741
| -43% | -$165K | ﹤0.01% | 1882 |
|
|
2023
Q3 | $298K | Buy |
38,927
+6,818
| +21% | +$52.2K | ﹤0.01% | 1904 |
|
|
2023
Q2 | $240K | Sell |
32,109
-22,901
| -42% | -$171K | ﹤0.01% | 1511 |
|
|
2023
Q1 | $367K | Buy |
55,010
+26,988
| +96% | +$180K | ﹤0.01% | 1786 |
|
|
2022
Q4 | $216K | Buy |
28,022
+9,882
| +54% | +$76.2K | ﹤0.01% | 1932 |
|
|
2022
Q3 | $193K | Buy |
18,140
+6,373
| +54% | +$67.8K | ﹤0.01% | 2096 |
|
|
2022
Q2 | $96K | Buy |
+11,767
| New | +$96K | ﹤0.01% | 2864 |
|
|
2022
Q1 | – | Sell |
-22,842
| Closed | -$391K | – | 2909 |
|
|
2021
Q4 | $391K | Buy |
22,842
+10,576
| +86% | +$181K | ﹤0.01% | 2085 |
|
|
2021
Q3 | $282K | Buy |
+12,266
| New | +$282K | ﹤0.01% | 2751 |
|